Cargando…

RSV Prevention in All Infants: Which Is the Most Preferable Strategy?

Respiratory syncytial virus (RSV) causes a spectrum of respiratory illnesses in infants and young children that may lead to hospitalizations and a substantial number of outpatient visits, which result in a huge economic and healthcare burden. Most hospitalizations happen in otherwise healthy infants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Susanna, Abu Raya, Bahaa, Baraldi, Eugenio, Flanagan, Katie, Martinon Torres, Federico, Tsolia, Maria, Zielen, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096079/ https://www.ncbi.nlm.nih.gov/pubmed/35572550 http://dx.doi.org/10.3389/fimmu.2022.880368

Ejemplares similares

1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005
por: Martinon-Torres, Federico, et al.
Publicado: (2018)

Pharmacokinetics, Safety, and Antiviral Effects of Multiple Doses of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678, in Infants Hospitalized With RSV Infection: A Randomized Phase 1b Study
por: Martinón-Torres, Federico, et al.
Publicado: (2020)

The assessment of future RSV immunizations: How to protect all infants?
por: Bont, Louis, et al.
Publicado: (2022)

Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper
por: Esposito, Susanna, et al.
Publicado: (2021)

Why has the epidemiology of RSV changed during the COVID-19 pandemic?
por: Abu-Raya, Bahaa, et al.
Publicado: (2023)

RSV: perspectives to strengthen the need for protection in all infants
por: Navarro Alonso, Jose Antonio, et al.
Publicado: (2021)

RSV disease in infants and young children: Can we see a brighter future?
por: Baraldi, Eugenio, et al.
Publicado: (2022)

Meeting Report: Harmonization of RSV therapeutics – from design to performance
por: Nair, Harish, et al.
Publicado: (2016)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
por: Gastaldi, Andrea, et al.
Publicado: (2021)

89. The Impact of Nirsevimab on an RSV Season in All Infants: Data From The HARMONIE Study
por: Faust, Saul N, et al.
Publicado: (2023)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Which characteristic of Natto: appearance, odor, or taste most affects preference for Natto
por: Tsumura, Yuki, et al.
Publicado: (2012)

The Immune System of HIV-Exposed Uninfected Infants
por: Abu-Raya, Bahaa, et al.
Publicado: (2016)

Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model
por: Kieffer, Alexia, et al.
Publicado: (2022)

Short-term antibiotic therapy for the most common bacterial respiratory infections in infants and children
por: Principi, Nicola, et al.
Publicado: (2023)

The Differences Between RSV and no RSV Acute Bronchiolitis in Hospitalized Infants: A Cross-Sectional Study
por: Christou, Evangelos, et al.
Publicado: (2022)

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12–23 Months of Age
por: Díez-Domingo, Javier, et al.
Publicado: (2022)

Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
por: Bollani, Lina, et al.
Publicado: (2015)

Transient Hypercalcemia in Preterm Infants: Insights Into Natural History and Laboratory Evaluation
por: Abu Raya, Bahaa, et al.
Publicado: (2014)

M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2017)

Respiratory Syncytial Virus (RSV)–Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants
por: Koivisto, Karoliina, et al.
Publicado: (2021)

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
por: Wilkins, Deidre, et al.
Publicado: (2023)

1936. Efficacy of One Dose of the Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Adults ≥ 60 Years of Age Persists for 2 RSV Seasons
por: Ison, Michael G, et al.
Publicado: (2023)

Eosinophil Cationic Protein and Chemokines in Nasopharyngeal Secretions of Infants with Respiratory Syncytial Virus (RSV) Bronchiolitis and Non-RSV Bronchiolitis
por: Kim, Hyun Hee, et al.
Publicado: (2007)

Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal()
por: Chu, Helen Y., et al.
Publicado: (2017)

The Use of Albuterol in Young Infants Hospitalized with Acute RSV Bronchiolitis
por: Del Vecchio, Michael T., et al.
Publicado: (2012)

Prevalence of infant bronchiolitis‐coded healthcare encounters attributable to RSV
por: Turi, Kedir N., et al.
Publicado: (2018)

Transplacental transfer of RSV antibody in Australian First Nations infants
por: Homaira, Nusrat, et al.
Publicado: (2022)

RSV hospitalisation and healthcare utilisation in moderately prematurely born infants
por: Shefali-Patel, Deena, et al.
Publicado: (2012)

Nasal and Fecal Microbiota and Immunoprofiling of Infants With and Without RSV Bronchiolitis
por: Alba, Claudio, et al.
Publicado: (2021)

A Single Dose Monoclonal Antibody (mAb) Immunoprophylaxis Strategy to Prevent RSV Disease in All Infants: Results of the First in Infant Study with MEDI8897
por: Domachowske, Joseph B, et al.
Publicado: (2017)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: A systematic review and meta–analysis
por: Chan, Markus, et al.
Publicado: (2017)

1526. The economic impact of respiratory syncytial virus (RSV) in infants in the United States: systematic literature review
por: Bowser, Diana, et al.
Publicado: (2020)

Which theory has the most holes?
Publicado: (2008)

Which Is the Most Significant Cause of Aging?
por: Liochev, Stefan I.
Publicado: (2015)

Which legal procedure affects business investment most, and which companies are most sensitive? Evidence from microdata()
por: Dejuan-Bitria, Daniel, et al.
Publicado: (2021)

2770. Intrapulmonary Vaccination with an M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against an RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2019)

Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life
por: Buchwald, Andrea G, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vpus65uq47vdfmjmq9kh17gua9